文献速递区域麻醉与超声疼痛医学

全膝关节置换术三种镇痛方案随机对照试验:连续股神经+单次坐骨神经阻滞与罗哌卡因或脂质体布比卡因关节周围注射的比较

A Three-arm Randomized Clinical Trial Comparing Continuous Femoral Plus Single-injection Sciatic Peripheral Nerve Blocks versus Periarticular Injection with Ropivacaine or Liposomal Bupivacaine for Patients Undergoing Total Knee Arthroplasty.
PubMed 文献 · Anesthesiology · 2017-01-01

这项三臂非盲随机试验纳入165例单侧初次全膝关节置换术成人,比较连续股神经+坐骨神经阻滞、罗哌卡因关节周围注射和脂质体布比卡因关节周围注射。主要结局为术后第1天最大疼痛评分,结果显示神经阻滞在术后第0天疼痛控制优于两种注射,但罗哌卡因注射在术后第1天和第2天疼痛控制与神经阻滞相当;脂质体布比卡因未显示优于罗哌卡因。

要点

  • 术后第0天,神经阻滞组最大和平均疼痛评分显著低于两种关节周围注射组。
  • 术后第1天,罗哌卡因注射组疼痛控制与神经阻滞组相当,脂质体布比卡因组最大疼痛评分较高。
  • 脂质体布比卡因关节周围注射未显示优于罗哌卡因注射。

核心结论

  • 罗哌卡因关节周围注射在术后第1天和第2天的疼痛控制与连续股神经加单次坐骨神经阻滞相当。
  • 脂质体布比卡因关节周围注射在全膝关节置换术中未显示优于罗哌卡因。

研究设计与样本

  • 三臂非盲随机对照试验,纳入165例接受单侧初次全膝关节置换术的成人。
  • 随机分为三组:连续股神经+坐骨神经阻滞组、罗哌卡因关节周围注射组、脂质体布比卡因关节周围注射组。
  • 主要结局为术后第1天最大疼痛评分(0-10数字疼痛评分量表),采用意向性分析。

主要发现

  • 术后第1天最大疼痛评分中位数分别为3、4和4.5;术后第0天分别为1、4和5。
  • 术后第1天最大疼痛评分神经阻滞组显著低于脂质体布比卡因组(P=0.016;Hodges-Lehmann中位差[95%CI]=-1[-2至0])。
  • 麻醉后监护室出院后术后第0天,神经阻滞组最大和平均疼痛评分显著低于两种注射组:罗哌卡因组最大-2[-3至-1],P<0.001;平均-0.8[-1.3至-0.2],P=0.003;脂质体布比卡因组最大-3[-4至-2],P<0.001;平均-1.4[-2.0至-0.8],P<0.001。

临床怎么用

  • 对于全膝关节置换术患者,罗哌卡因关节周围注射可作为连续股神经加单次坐骨神经阻滞的替代镇痛方案,在术后第1天和第2天提供相当的疼痛控制。
  • 脂质体布比卡因关节周围注射未显示优于罗哌卡因,临床选择时需考虑成本效益。

局限性

  • 研究为非盲设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multimodal analgesia is standard practice for total knee arthroplasty; however, the role of regional techniques in improved perioperative outcomes remains unknown. The authors hypothesized that peripheral nerve blockade would result in lower pain scores and opioid consumption than two competing periarticular injection solutions. METHODS: This three-arm, nonblinded trial randomized 165 adults undergoing unilateral primary total knee arthroplasty to receive (1) femoral catheter plus sciatic nerve blocks, (2) ropivacaine-based periarticular injection, or (3) liposomal bupivacaine-based periarticular injection. Primary outcome was maximal pain during postoperative day 1 (0 to 10, numerical pain rating scale) in intention-to-treat analysis. Additional outcomes included pain scores and opioid consumption for postoperative days 0 to 2 and 3 months. RESULTS: One hundred fifty-seven study patients received peripheral nerve block (n = 50), ropivacaine (n = 55), or liposomal bupivacaine (n = 52) and reported median maximal pain scores on postoperative day 1 of 3, 4, and 4.5 and on postoperative day 0 of 1, 4, and 5, respectively (average pain scores for postoperative day 0: 0.6, 1.7, and 2.4 and postoperative day 1: 2.5, 3.5, and 3.7). Postoperative day 1 median maximal pain scores were significantly lower for peripheral nerve blockade compared to liposomal bupivacaine-based periarticular injection (P = 0.016; Hodges-Lehmann median difference [95% CI] = -1 [-2 to 0]). After postanesthesia care unit discharge, postoperative day 0 median maximal and average pain scores were significantly lower for peripheral nerve block compared to both periarticular injections (ropivacaine: maximal -2 [-3 to -1]; P < 0.001; average -0.8 [-1.3 to -0.2]; P = 0.003; and liposomal bupivacaine: maximal -3 [-4 to -2]; P < 0.001; average -1.4 [-2.0 to -0.8]; P < 0.001). CONCLUSIONS: Ropivacaine-based periarticular injections provide pain control comparable on postoperative days 1 and 2 to a femoral catheter and single-injection sciatic nerve block. This study did not demonstrate an advantage of liposomal bupivacaine over ropivacaine in periarticular injections for total knee arthroplasty.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Amundson AW, Johnson RL, Abdel MP, et al. A Three-arm Randomized Clinical Trial Comparing Continuous Femoral Plus Single-injection Sciatic Peripheral Nerve Blocks versus Periarticular Injection with Ropivacaine or Liposomal Bupivacaine for Patients Undergoing Total Knee Arthroplasty. Anesthesiology. 2017. PMID: 28234636. doi:10.1097/ALN.0000000000001586

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。